(XENT) - Earnings & Price History

XENT: - 28.5, $858.16M, -1.15 (-3.88%)

Sector: Healthcare - Industry: Medical Appliances & Equipment

Intersect ENT, Inc., a commercial stage drug-device company, provides therapeutic solutions for patients with ear, nose, and throat conditions in the United States. It offers PROPEL and PROPEL mini drug releasing implants for patients undergoing sinus surgery to treat chronic sinusitis. The company is also developing RESOLVE, a steroid releasing implant for refractory disease for the treatment of patients in the physician office setting; and NOVA, a steroid releasing implant to fit the ostia, or openings, of the dependent sinuses following enlargement of the sinuses. The company was formerly known as Sinexus, Inc. and changed its name to Intersect ENT, Inc. in November 2009. Intersect ENT, Inc. was founded in 2003 and is headquartered in Menlo Park, California.Key Statistics

Past XENT reports
Earning DateTimeTitleEPS-e EPS-a ClosePrev CloseOpen Day LowDay High Gap % CFO %Change % Volume
2017-02-28AMC-0.214.413.613.913.1514.952.21%3.60%5.88%400.84K
2016-11-02AMC-0.279.258.3510.158.7510.1921.56%▲-8.87%10.78%2.26M
2016-08-02AMC-0.2616.3716.02161617-0.12%2.31%2.18%514.48K
2016-05-05AMC-0.2913.8120.3417.5213.617.61-13.86%-21.18%-32.10%2.65M
2016-02-23AMC-0.2518.4517.5817.9417.8318.982.05%2.84%4.95%665.78K
2015-11-04AMC-0.2916.5421.6916.715.7417.2-23.01%▲-0.96%-23.74%5.64M
2015-08-05AMC-0.2629.9830.2129.9129.2930.8-0.99%0.23%-0.76%70.59K
2015-05-06-0.3324.0425.8525.8522.8825.86-7.00%-7.00%402.91K
2014-11-05AMCIntersect Ent-0.3217.9917.8718.817.3618.85.20%▲-4.31%0.67%57.10K
2014-09-03AMCIntersect Ent-0.28-2.3616.5315.1615.1215.1216.79-0.26%9.33%9.04%58.70K

Login | Register
Friday Nov 16, 2018   EST
Enter a Ticker:

Economic Calendar

AAII Sentiment Survey

BULL^ neut ^ BEAR

Chart

index chart
index color
SPY257.6450.500.19%41,867,194

Upgrades/Downgrades